Nova Leap Health Corp.
NLH.VTSXVHealthcare● Active
$0.37
+$0.00(+1.35%)
Market Cap$32306273
P/E Ratio—
52W High$0.44
52W Low$0.22
Nova Leap Health Corp. (NLH.V) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NLH.V · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $32.02M | $25.76M | $26.18M | $28.21M | $21.28M |
| Cost of Revenue | $20.16M | $15.87M | $16.41M | $18.23M | $14.07M |
| Gross Profit | $11.85M | $9.89M | $9.77M | $9.98M | $7.21M |
| Gross Margin %(computed) | 37.03% | 38.38% | 37.31% | 35.37% | 33.89% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $8.44M | $8.42M | $9.68M | $7.58M |
| Total Operating Expenses | $10.73M | $9.02M | $9.31M | $11.04M | $3.32M |
| Operating Income | $1.13M | $0.86M | $0.46M | ($1.10M) | $3.89M |
| Operating Margin %(computed) | 3.51% | 3.35% | 1.76% | -3.90% | 18.30% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.36M | $0.11M | $0.14M | $0.27M | $0.40M |
| Income Before Tax | ($0.13M) | $1.81M | ($1.37M) | ($1.21M) | $2.47M |
| Income Tax Expense | $0.06M | $0.43M | ($0.31M) | ($0.37M) | $0.71M |
| Net Income | ($0.19M) | $1.38M | ($1.05M) | ($0.84M) | $1.76M |
| Net Margin %(computed) | -0.60% | 5.35% | -4.03% | -2.96% | 8.27% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.00 | $0.02 | $-0.01 | $-0.01 | $0.02 |
| Wtd Avg Shares | 87.31M | 87.54M | 86.22M | 77.65M | 74.40M |
| EBITDA | $1.97M | $2.50M | $0.99M | $0.42M | $4.76M |
| EBITDA Margin %(computed) | 6.16% | 9.71% | 3.80% | 1.49% | 22.35% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Nova Leap Health Corp. data
About Nova Leap Health Corp. (NLH.V) Income Statement
Nova Leap Health Corp. (NLH.V) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NLH.V reported revenue of $0.03B, gross profit of $0.01B (gross margin 37.03%), and net income of ($0.00B) — a net profit margin of -0.60%.
Frequently asked questions
NLH.V · 4 questionsNova Leap Health Corp. (NLH.V) reported revenue of $0.03B for 2025, up 24.3% year-over-year.
NLH.V revenueNLH.V salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08